Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
49.97
-0.03 (-0.06%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.
Employees
323
Change (1Y)
79
Growth (1Y)
32.38%
Revenue / Employee
$566,418
Profits / Employee
-$357,752
Market Cap
2.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
TARS News
- 13 hours ago - Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - GlobeNewsWire
- 2 days ago - Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting - GlobeNewsWire
- 6 weeks ago - Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewsWire
- 6 weeks ago - Tarsus Announces Proposed $100.0 Million Public Offering - GlobeNewsWire
- 6 weeks ago - Tarsus Pharma: Strong Execution In Xdemvy Commercialization - Seeking Alpha
- 7 weeks ago - Tarsus to Participate in Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - GlobeNewsWire